1. Home
  2. MED vs IXHL Comparison

MED vs IXHL Comparison

Compare MED & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$11.36

Market Cap

120.6M

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.29

Market Cap

134.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MED
IXHL
Founded
1980
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
120.6M
134.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MED
IXHL
Price
$11.36
$0.29
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
224.0K
7.8M
Earning Date
02-17-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$429,695,000.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$470.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$0.08
52 Week High
$16.66
$2.24

Technical Indicators

Market Signals
Indicator
MED
IXHL
Relative Strength Index (RSI) 40.44 27.26
Support Level $10.81 $0.25
Resistance Level $11.31 $0.34
Average True Range (ATR) 0.43 0.02
MACD -0.09 -0.01
Stochastic Oscillator 0.75 10.06

Price Performance

Historical Comparison
MED
IXHL

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: